Sign In
Buy MRNA
$47.44
-4.15 (-8.04%)
At Close: Jun 05, 2026
Why Moderna Stock Triumphed on Thursday
10:09pm, Thursday, 08'th Sep 2022 The Motley Fool
A prognosticator is particularly hopeful for the company's planned triple vaccine.
Why Moderna Stock Triumphed on Thursday
06:09pm, Thursday, 08'th Sep 2022
A prognosticator is particularly hopeful for the company's planned triple vaccine.
Here's Why These Top 3 COVID-19 Vaccine Stocks Broke Down in August
05:00pm, Thursday, 08'th Sep 2022 The Motley Fool
Pfizer, Moderna, and Novavax all had a rough month in August.
What To Know About Deutsche Bank's Upgrade of Moderna
04:14pm, Thursday, 08'th Sep 2022 Benzinga
Deutsche Bank upgraded its rating of Moderna (NASDAQ:MRNA) to Buy with a price target of $165.00, changing its price target from $155.00 to $165.00.
Shares of Moderna are trading up 4.28% over the las
4 Analysts Have This to Say About Moderna
02:56pm, Thursday, 08'th Sep 2022 Benzinga
Within the last quarter, Moderna (NASDAQ:MRNA) has observed the following analyst ratings:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
1
0
1
2
0
Last 30D
1
0
Benzinga's Top Ratings Upgrades, Downgrades For September 8, 2022
02:15pm, Thursday, 08'th Sep 2022 Benzinga
Upgrades
For World Wrestling Entertainment Inc (NYSE:WWE), Wolfe Research upgraded the previous rating of Peer Perform to Outperform. For the second quarter, World Wrestling Enter had an EPS of $0.59
2 Top Healthcare Stocks to Buy for September
02:15pm, Thursday, 08'th Sep 2022 The Motley Fool
These companies bring different strengths and opportunities to a stock portfolio.
Moderna To $165? Plus This Analyst Cuts PT On FedEx
01:46pm, Thursday, 08'th Sep 2022 Benzinga
Deutsche Bank raised the price target on Moderna, Inc. (NASDAQ: MRNA) from $155 to $165. Deutsche Bank analyst Emmanuel Papadakis also upgraded the stock from Hold to Buy. Moderna shares rose 2.8% to
Where Moderna Stands With Analysts
01:28pm, Thursday, 08'th Sep 2022 Benzinga
Analysts have provided the following ratings for Moderna (NASDAQ:MRNA) within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
1
0
1
2
0
Last 30
U.S. COVID-19 vaccine market could be up to $13 billion-Moderna exec
12:25pm, Thursday, 08'th Sep 2022
Vaccine maker Moderna Inc's chief commercial officer (CCO) said on Thursday that the size of the future COVID-19 vaccine market in the United States could be in the range of $5.2 billion to $12.9 bill
These Analysts Slash Price Targets On NIO, Plus Wells Fargo Predicts $120 For PayPal
12:20pm, Thursday, 08'th Sep 2022 Benzinga
Mizuho cut the price target for NIO Inc. (NYSE: NIO) from $48 to $42. NIO shares rose 0.1% to $17.50 in pre-market trading.
Citigroup cut the price target on NIO Inc. (NYSE: NIO) from $41.1 to $31.3
Put Option Strategy To Generate 11.2% Yield On Cash Or Own Moderna At $82
10:37am, Thursday, 08'th Sep 2022
Put options are a way to generate yield with downside protection. MRNA's high volatility makes selling options more attractive.
Moderna Stock Moves Higher on Upgrade to "Buy"
10:06am, Thursday, 08'th Sep 2022
Moderna Inc (NASDAQ:MRNA) received an upgrade from Deutsche Bank to "buy" from "hold" this morning, as well as a price-target hike to $165 from $155.
For Moderna, Valuation Still A Question Mark
02:40pm, Wednesday, 07'th Sep 2022 Investing.com
Why Moderna Stock Slumped Today
08:49pm, Tuesday, 06'th Sep 2022 The Motley Fool
New vaccine guidelines by U.S. health authorities may dampen sales of the biotech's top coronavirus vaccine.
